<VariationArchive RecordType="classified" VariationID="830781" VariationName="NC_000011.10:g.(?_64750366)_(64750593_?)del" VariationType="Deletion" Accession="VCV000830781" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="820397" VariationID="830781">
      <GeneList>
        <Gene Symbol="PYGM" FullName="glycogen phosphorylase, muscle associated" GeneID="5837" HGNC_ID="HGNC:9726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="64746389" stop="64760715" display_start="64746389" display_stop="64760715" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="64513860" stop="64528186" display_start="64513860" display_stop="64528186" Strand="-" />
          </Location>
          <OMIM>608455</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000011.10:g.(?_64750366)_(64750593_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" innerStart="64517838" innerStop="64518065" display_start="64517838" display_stop="64518065" variantLength="228" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.(?_64517838)_(64518065_?)del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.(?_64517838)_(64518065_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.10:g.(?_64750366)_(64750593_?)del AND Glycogen storage disease, type V" Accession="RCV001031388" Version="1">
        <ClassifiedConditionList TraitSetID="585">
          <ClassifiedCondition DB="MedGen" ID="C0017924">Glycogen storage disease, type V</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-01-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-01-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19251976</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29382405</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="585" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2239" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">McArdle disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">McArdle type glycogen storage disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscle glycogen phosphorylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myophosphorylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease, type V</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+5/3125" DB="Genetic Alliance" />
                <XRef ID="55912009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD5</ElementValue>
                <XRef Type="MIM" ID="232600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GSD V</ElementValue>
                <XRef Type="MIM" ID="232600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6528" />
                <XRef ID="6528" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type V (GSDV, McArdle disease) is a metabolic myopathy characterized by exercise intolerance manifested by rapid fatigue, myalgia, and cramps in exercising muscles. Symptoms are usually precipitated by isometric exercise or sustained aerobic exercise. Most individuals improve their exercise tolerance by exploiting the "second-wind" phenomenon with relief of myalgia and fatigue after a few minutes of rest. Age of onset is frequently in the first decade of life but can vary; however, diagnosis is typically delayed as myalgia and fatigability are dismissed/overlooked. Fixed muscle weakness occurs in approximately 25% of affected individuals, is more likely to involve proximal muscles, and is more common in individuals of advanced age. Approximately 50% of affected individuals have recurrent episodes of myoglobinuria that can – on occasion – eventually result in acute renal failure.</Attribute>
                <XRef ID="NBK1344" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301518</ID>
                <ID Source="BookShelf">NBK1344</ID>
              </Citation>
              <XRef ID="368" DB="Orphanet" />
              <XRef ID="C0017924" DB="MedGen" />
              <XRef ID="MONDO:0009293" DB="MONDO" />
              <XRef Type="MIM" ID="232600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2355948" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-15" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4605896|MedGen:C0017924" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194694" DateUpdated="2020-04-15" DateCreated="2020-04-15" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19251976</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29382405</ID>
          </Citation>
          <Comment>This variant is an out-of-frame deletion of the genomic region encompassing exon 17 of the PYGM gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. Similar deletions affecting exon 17 have been observed in individuals affected with PYGM-related conditions (PMID: 19251976, 29382405). Loss-of-function variants in PYGM are known to be pathogenic (PMID: 8316268, 16786513). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PYGM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.(?_64517838)_(64518065_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Glycogen storage disease, type V</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0017924" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2355948" TraitType="Disease" MappingType="Name" MappingValue="Glycogen storage disease, type V" MappingRef="Preferred">
        <MedGen CUI="C0017924" Name="Glycogen storage disease, type V" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

